The plant, announced in May 2025, was slated to open in the first quarter of this year, bringing 170 jobs to Plano’s Legacy ...
SHANGHAI, Jan 27 (Reuters) - Chinese drugmaker Qilu Pharmaceutical will be responsible for developing metabolic disease drug candidates from Insilico Medicine under a contract with a total value that ...
Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its ...
WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...
The buyer is Siegfried Holding AG, a global contract development and manufacturing organization for the pharmaceutical industry.
HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...
Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...
China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...
A facility that manufactures products for pharmaceutical companies is set to eliminate one of its two Massachusetts ...
Pharmaceuticals used in health care provide huge health and economic benefits to society, but are now found extensively as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results